Mar 11, 2021 / 07:00PM GMT
Anthony Charles Petrone - Jefferies LLC, Research Division - Healthcare Analyst
Thank you, everyone, for joining us for the afternoon session of the First Annual Jefferies Global Plasma Summit. With us, up next, we're happy to have in attendance Cerus Corporation. We have Obi Greenman, the company's CEO. We have Kevin Green, the company's CFO. I'm going to hand it off to Obi, who'll go through some initial slides, and then we'll go into a Q&A session. Thank you both for joining us. And over to you, Obi. Thank you.
William M. Greenman - Cerus Corporation - President, CEO & Director
Yes. Thanks a lot, Anthony, and I want to thank Jefferies for the opportunity to present today. I'm going to go through a few slides just to give you a background of the company. But before I do that, I just wanted to make sure that I alert you to the forward-looking statements I'll be making today and our risk factors in the Forms 10-Q and 10-K.
Next slide, Matt. So as a company, we have a very simple mission, and it's to make our INTERCEPT systems for the pathogen
Cerus Corp at Jefferies Virtual Plasma Summit Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot